Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles
Open accessAbstract
The development of safe and efficacious gene vectors has limited greatly the potential for therapeutic treatments based on messenger RNA (mRNA). Lipid nanoparticles (LNPs) formed by an ionizable cationic lipid (here DLin-MC3-DMA), helper lipids (distearoylphosphatidylcholine, DSPC, and cholesterol), and a poly(ethylene glycol) (PEG) lipid have been identified as very promising delivery vectors of short interfering RNA (siRNA) in different clinical phases; however, delivery of high-molecular weight RNA has been proven much more demanding. Herein we elucidate the structure of hEPO modified mRNA-containing LNPs of different sizes and show how structural differences affect transfection of human adipocytes and hepatocytes, two clinically relevant cell types. Employing small-angle scattering, we demonstrate that LNPs have a disordered inverse hexagonal internal structure with a characteristic distance around 6 nm in presence of mRNA, whereas LNPs containing no mRNA do not display this structure. Furthermore, using contrast variation small-angle neutron scattering, we show that one of the lipid components, DSPC, is localized mainly at the surface of mRNA-containing LNPs. By varying LNP size and surface composition we demonstrate that both size and structure have significant influence on intracellular protein production. As an example, in both human adipocytes and hepatocytes, protein expression levels for 130 nm LNPs can differ as much as 50-fold depending on their surface characteristics, likely due to a difference in the ability of LNP fusion with the early endosome membrane. We consider these discoveries to be fundamental and opening up new possibilities for rational design of synthetic nanoscopic vehicles for mRNA delivery.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Inside the core, the main part of the ionizable cationic lipid, cholesterol (dependent on its concentration), water and mRNA are present.
“Inside the core, the main part of the ionizable cationic lipid, cholesterol (dependent on its concentration), water and mRNA are present.”
From mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability (2021) · cites this paper as Yanez Arteta et al., 2018
The isotropic LNP core consists for 24% (volume fraction) of water.
“Interestingly, their research indicates that the isotropic LNP core consists for 24% (volume fraction) of water.”
From mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability (2021) · cites this paper as Yanez Arteta et al., 2018
The mRNA is -at least partly- exposed to water inside the LNPs, which likely contributes to its instability upon storage under non-frozen conditions.
“This would mean that the mRNA is –at least partly– exposed to water inside the LNPs, which likely contributes to its instability upon storage under non-frozen conditions (Arteta et al., 2018).”
From mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability (2021) · cites this paper as Arteta et al., 2018
A key aspect of LNPs is the presence of lipids in the core, although water is also present to some extent.
“A key aspect of LNPs and the characteristic that makes them different from liposomes (spherical vesicles with at least one lipid bilayer and an aqueous core) is the presence of lipids in the core, although data from several studies indicate that water is also present to some extent (Yanez Arteta et al., 2018, Kulkarni et al., 2018, Brader et al., 2021).”
From mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability (2021) · cites this paper as Yanez Arteta et al., 2018
Arteta et al. found that DSPC and PEG-lipid as well as part of the ionizable cationic lipid and cholesterol are located on the surface of the LNPs.
“They found that 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC) and PEG-lipid as well as part of the ionizable cationic lipid and cholesterol are located on the surface of the LNPs.”
From mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability (2021) · cites this paper as Yanez Arteta et al., 2018
In mRNA-LNP formulations, the fraction of accessible mRNA is very low and encapsulation efficiencies are typically > 90%.
“In mRNA-LNP formulations, such as those used in mRNA vaccines, the fraction of accessible mRNA is very low (Yanez Arteta et al., 2018, Patel et al., 2020) and thus, encapsulation efficiencies, derived from RiboGreen assays, are typically > 90%.”
From mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability (2021) · cites this paper as Yanez Arteta et al., 2018
The shell of Arteta et al.'s mRNA-LNPs is a monolayer.
“Another interesting finding by Arteta et al. is that the shell of their mRNA-LNPs is a monolayer (Yanez Arteta et al., 2018, Verbeke et al., 2019).”
From mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability (2021) · cites this paper as Yanez Arteta et al., 2018
mRNA LNPs with enriched DSPC content at the surface (approaching an almost pure monolayer of DSPC) exhibit weak transfection capacity.
“By contrast, mRNA LNPs with an enriched DSPC content at the surface (approaching an almost pure monolayer of DSPC) exhibited a weak transfection capacity.”
From Three decades of messenger RNA vaccine development (2019) · cites this paper as [113]
By adjusting the molar ratios of different lipids, mRNA LNPs with varying surface characteristics can be produced.
“Interestingly, by adjusting the molar ratios of the different lipids, the authors could produce mRNA LNPs with varying surface characteristics.”
From Three decades of messenger RNA vaccine development (2019) · cites this paper as [113]
The core of these LNPs is surrounded by a lipid monolayer containing mainly DSPC and DMPE-PEG2000, as well as a fraction of D-Lin-MC3-DMA and cholesterol.
“This core was surrounded by a lipid monolayer containing mainly the DSPC and DMPE-PEG2000 content, as well as a fraction of D-Lin-MC3-DMA and cholesterol [113].”
From Three decades of messenger RNA vaccine development (2019) · cites this paper as [113]
LNP compositions that favour partial segregation of D-Lin-MC3-DMA from the internal core to the outer surface correlate with increased transfection efficiency.
“They found that LNP compositions that favour a partial segregation of D-Lin-MC3-DMA lipids from the internal core to the outer surface, correlated with an increased transfection efficiency.”
From Three decades of messenger RNA vaccine development (2019) · cites this paper as [113]
mRNA LNPs based on D-Lin-MC3-DMA, DSPC, cholesterol and a PEG-lipid exhibit a disordered inverse hexagonal phase containing D-Lin-MC3-DMA, cholesterol, water and mRNA.
“In another study, Yanez Arteta et al. indicated that the structural arrangement of mRNA LNPs based on D-Lin-MC3-DMA, DSPC, cholesterol and a PEG-lipid exhibited a disordered inverse hexagonal phase containing D-Lin-MC3-DMA, cholesterol, water and mRNA.”
From Three decades of messenger RNA vaccine development (2019) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 40 · Cited by 534
- Authors
- Yanez Arteta, M., Kjellman, T., Bartesaghi, S., Wallin, S., Wu, X., Kvist, A. J., Dabkowska, A., Székely, N., Radulescu, A., Bergenholtz, J., & Lindfors, L.
- Affiliations
- Pharmaceutical Sciences iMed Biotech Unit, AstraZeneca R&D Gothenburg, 431 83 Mölndal, Sweden;
- AstraZeneca (Sweden) (SE)
- Outstation at Maier-Leibnitz Zentrum, Jülich Centre for Neutrons Science, 857 47 Garching, Germany;
- University of Gothenburg (SE)
- Corresponding author
- Lindfors, Lennart
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2018-03-27
- Volume
- 115
- Issue
- 15
- Pages
- E3351-E3360
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5899464
- OpenAlex
- W2794867971
- Cited by
- 534
- References
- 40
- Citations by year
- 2026: 58 · 2025: 96 · 2024: 93 · 2023: 82 · 2022: 83 · 2021: 67 · 2020: 32 · 2019: 20 · 2018: 3
- FWCI
- 10.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- iMPULSE (Heinz Maier-Leibnitz Zentrum) (submittedVersion, cc-by-nc-nd)
- Funders
- National Science Foundation (0520547)
- AstraZeneca
- Chalmers Tekniska Högskola
- Lunds Universitet
- Uppsala Universitet
- Division of Materials Research (0520547, DMR‐0520547)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Keywords
- lipid nanoparticles, mRNA delivery, distearoylphosphatidylcholine, PEG-lipids, small-angle neutron scattering, small-angle X-ray scattering, human adipocytes, hepatocytes, protein expression, surface composition
- MeSH terms
- Erythropoietin, Humans, Lipids, Particle Size, RNA, Messenger, Transfection, Drug Delivery Systems, Adipocytes, Hepatocytes, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review